Major Histocompatibility Complex Class II Deficiency Complicated by Mycobacterium avium Complex in a Boy of Mixed Ethnicity

Journal of Clinical Immunology

Volumn 34, Issue 6, 2014, Pages 677-680

  Dimitrova, Dimana ^a   Ong, Peck Y ^a   O’Gorman, Maurice R G ^a   Church, Joseph A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bare lymphocyte syndrome; class II transactivator; major histocompatibility complex class II deficiency; Mycobacterium avium complex

Indexed keywords

HLA DR ANTIGEN; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ADOLESCENT; B LYMPHOCYTE; CASE REPORT; DEVELOPMENTAL DISABILITIES; ETHNIC GROUP; GENE DELETION; GENETICS; HOMOZYGOTE; HUMAN; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; MALE; METABOLISM; MEXICAN AMERICAN; MONOCYTE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NUCLEOTIDE SEQUENCE; PARENT; PEDIGREE; PHYSIOLOGY; PRESCHOOL CHILD; X CHROMOSOME;

ADOLESCENT; B-LYMPHOCYTES; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MEXICAN AMERICANS; MONOCYTES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NUCLEAR PROTEINS; PARENTS; PEDIGREE; SEQUENCE DELETION; TRANS-ACTIVATORS;

EID: 84939872978     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0048-x     Document Type: Article

References (18)

1. DeSandro A, Nagarajan UM, Boss JM. The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am J Hum Genet. 1999;65(2):279–86.
2. Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005;5(10):793–806.
3. Djidjik R, Messaoudani N, Tahiat A, Meddour Y, Chaib S, Atek A, et al. Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency. Allergy Asthma Clin Immunol. 2012;8(1):14.
4. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr. 1993;123(6):921–8.
5. Saleem MA, Arkwright PD, Davies EG, Cant AJ, Veys PA. Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child. 2000;83(4):356–9.
6. Bontron S, Steimle V, Ucla C, Eibl MM, Mach B. Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum Genet. 1997;99(4):541–6.
7. Repique CJ, Li A, Brickey WJ, Ting JP, Collins FM, Morris SL. Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis. Scand J Immunol. 2003;58(1):15–22.
8. Mertens G, DeSmet D, Gielis M. A case of chronic granulomatous skin disease associated with deficient HLA class I expression. Br J Dermatol. 2000;143:659–60.
9. Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, et al. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. Lancet. 1999;354(9190):1598–603.
10. Harshan KV, Gangadharam PR. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun. 1991;59(8):2818–21.
11. Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses and myelodysplasia. Blood. 2010;115:1519–29.
12. Acree SC, Tovar JP, Pattengale PK, Wang LL, Church JA, Gaynon PS, et al. Subcutaneous panniculitis-like T-cell lymphoma in two pediatric patients: an HIV-positive adolescent and a 4-month-old infant. Fetal Pediatr Pathol. 2013;32(3):175–83.
13. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396(6712):690–5.
14. Kuo CY, Chase J, Garcia Lloret M, Stiehm ER, Moore T, Aguilera MJ, et al. Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome. J Allergy Clin Immunol. 2013;131(6):1693–5.
15. El-Hattab AW, Fang P, Jin W, Hughes JR, Gibson JB, Patel GS, et al. Int22h-1/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions. J Med Genet. 2011;48(12):840–50.
16. Bartsch O, Gebauer K, Lechno S, van Esch H, Froyen G, Bonin M, et al. Four unrelated patients with Lubs X-linked mental retardation syndrome and different Xq28 duplications. Am J Med Genet A. 2010;152A(2):305–12.
17. Vandewalle J, Van Esch H, Govaerts K, Verbeeck J, Zweier C, Madrigal I, et al. Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination. Am J Hum Genet. 2009;85(6):809–22.
18. Stern MH, Soulier J, Rosenzwajg M, Nakahara K, Canki-Klain N, Aurias A, et al. MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. Oncogene. 1993;8(9):2475–83.